Traders: Most Active Stocks: (OTCBB: CTDT), (NASDAQ: HGSI), (NASDAQ: AAPL), (NASDAQ: MAT)
17 Luglio 2012 - 6:16PM
Marketwired
PennyStockChief.com is the #1 leader for breaking news, offering
quality reports to investors looking for the most undervalued
companies in the market. The chief provides its subscribers with
timely information and exclusive analysis on U.S. companies with
substantial upside potential. The Chief is issuing reports on the
following equities:
Centaurus Diamond Technology (OTCBB: CTDT), Apple Inc. (NASDAQ:
AAPL), Human Genome Sciences Inc (NASDAQ: HGSI), Mattel Inc
(NASDAQ: MAT)
Centaurus Diamond Technology (OTCBB:
CTDT)
CTDT is pleased to announce that it has signed an agreement with
Tabco Products Inc. ("Tabco") for the development of its unique
Centaurus' Magnatech Diamond Technology process. This patented
technology enables the production of "cultured" diamonds that are
chemically, atomically and structurally identical to natural
diamonds. Centaurus' unique process applies a collapsing magnetic
field to a carbon sample thereby changing its crystalline structure
to that of a diamond.
For Free Trend Analysis Report here:
http://pennystockchief.com/ticker.php?ticker=CTDT
Apple Inc. (NASDAQ: AAPL)
AAPL is currently down $2.47(.40%). Open price of $610.79 and
hitting a high of $611.50. Could the new product features send the
stock to higher levels?
For Free Trading Analysis Report Here:
http://pennystockchief.com/ticker.php?ticker=AAPL
Human Genome Sciences Inc (NASDAQ: HGSI)
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor,
LLP are investigating the sale of Human Genome Sciences ("HGSI")
(NASDAQ: HGSI) to GlaxoSmithKline plc for shareholders. Under the
proposed transaction, HGSI shareholders will only receive $14.25 in
cash for each share of HGSI stock owned, well below the 52 week
high of $23.84.
For Free Trading Analysis Report Here and more information on
the investigation:
http://pennystockchief.com/ticker.php?ticker=HGSI
Mattel Inc (NASDAQ: MAT)
Today, MAT reported 2012 second quarter financial results. For
the quarter, the Company reported net income of $96.2 million, or
$0.28 per share, compared to last year's second quarter net income
of $80.5 million, or $0.23 per share.
For Free Trading Analyisis Report Here:
http://pennystockchief.com/ticker.php?ticker=MAT
This report is for information purposes only, and is neither a
solicitation to buy nor an offer to sell securities. Information,
opinions and analysis contained herein are based on sources deemed
to be reliable and are subject to change without notice. A third
party has hired and paid IO NewsWire one thousand two hundred and
ninety five dollars for the publication and circulation of this
news release. Accordingly, certain information included herein may
be forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995. However, no representation,
expressed or implied, is made as to the accuracy, completeness or
correctness. In light of the above, we accept no liability for any
losses arising from an investor's reliance on or use of this
report. We do not and have not had any ownership interest in said
third party of any kind.
IO NewsWire editor@ionewswire.com
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Giu 2023 a Giu 2024